Questa Capital: Company Market Research Report

Company Overview

• Name: Questa Capital

• Mission: To generate outstanding returns for investors and management teams by investing and supporting innovative healthcare leaders in building the next generation of growth companies.

• Founded: No information is available.

• Founders: No information is available.

• Key People:

• Ryan Drant, Founder and Managing Partner

• Bradley Sloan, Managing Partner

• Shawn Conway, Chief Operating Officer

• Justin Kirkpatrick, Partner

• Aabed Meer, MD, Partner

• Brian Butler, Partner

• Joe Huang, Vice President of Finance

• Steph Scott, Vice President

• Evans Grenier, Vice President

• Eric Thakor, Vice President

• Chandler Lally, Vice President

• Sanghamithra Kalimi, Associate

• David Liu, Associate

• Jonathan Li, Associate

• Shannon Melser, Operations Manager

• Iris Badiola, Executive Assistant

• Headquarters: Dual offices on East Coast (1156 15th Street NW, Suite 302, Washington, DC 20005) and West Coast (501 2nd Street, Suite 615, San Francisco, CA 94107).

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: Questa Capital is recognized for investing in healthcare companies, focusing on sectors like healthcare services, healthcare technology, and medical devices. The company is notable for partnering with high-integrity executives towards healthcare improvements and disruptive business models.

Products

• Investment Focus:

• Healthcare Services: Investments to accelerate growth and enhance service delivery efficiency.

• Healthcare Technology: Targeting technological innovation for better clinical outcomes at lower costs.

• Medical Devices: Investments backed by significant intellectual property creating competitive advantages.

Recent Developments

• Recent Developments:

• Calyxo: Announced 1-Year Study Results with CVAC System for Kidney Stone Clearance showing positive outcomes in Urolithiasis treatment.

• Prime/MRx: Launched Pharmacy Match technology to expand specialty pharmacy access.

• ACTO: Acquired 4th Down Solutions to strengthen its learning platform capabilities.

• Eko Health: Raised $41 million to scale AI-driven heart and lung disease detection technologies.

• New Products/Features:

• Eko Health CORE 500™: A digital stethoscope launched featuring heart disease detection AI, 3-Lead ECG, and advanced audio capabilities.

• Calyxo’s CVAC System: A redesigned system cleared by the FDA for kidney stone treatment.

• Partnerships and Other Developments:

• Intrinsic Therapeutics: Added new board members with experience in commercializing disruptive technologies.

• Avive Solutions: Raised $56.5M for building a connected AED network for cardiac arrest response.

• SamaCare: Secured $17M Series B investment for scaling its specialty drug prior authorization platform.

This report includes all the available information from the provided data. For any fields with unspecified data, no further information was found.